celltrion vegzelma permission canada

Celltrion Inc. and SK Biopharmaceuticals Co. are witnessing improving sales revenue and profitability by selling their products through their own ma...

South Korea’s top shipbuilder HD Hyundai Heavy Industries Co. is joining hands with major US defense technology firms to expand its presence i...

South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...

South Korea's Mirae Asset Global Investments Co. announced on Thursday that it will change the name of its Canadian exchange-traded fund (ETF) manag...

South Korea’s Hyundai Movex Co., the logistics automation solutions affiliate of Hyundai Group, announced on Wednesday that it signed a 20 bil...

South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tr...

Hyundai Motor Co. 's premium brand Genesis announced on Friday that its Electrified G80 and Electrified GV70 earned prizes at the 2024 Canadian Ca...

South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...

South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...

A state-run company in South Korea is set to seek an investor-state dispute settlement (ISDS) worth around 1 trillion won ($747.1 million) against t...

South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...

South Korea's Lotte Wellfood Co. announced on Tuesday that it is expanding exports to Mexico and Canada through Costco. It marks the first entry o...

South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...

South Korean biosimilar giant Celltrion Group is planning to debut on the Nasdaq market by early 2025, founder and Chairman Seo Jung-jin said at the...

Samsung SDI Co. has agreed to invest $18.5 million in Canada Nickel Company Inc. to secure steady supplies of nickel and cobalt, key materials for r...

South Korean investors’ years-long trading of spot-bitcoin exchange-traded funds (ETFs) listed in Canada and Germany was abruptly suspended du...

South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...

Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...

South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...

South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...

South Korean drone exports surged to $1.11 million in 2023, exceeding the government's target by more than four times, fueled by strong demand for d...

South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...

Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...

South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...

Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...

Korea Hydro and Nuclear Power Co. (KHNP) said on Wednesday it has signed a non-binding agreement with ARC Clean Technology Canada Inc. and New Bruns...

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...

LG Electronics Inc.'s automotive electronics production plants have surpassed 100% of their operating rate this year as of the end of September.Acco...

South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...